Results 61 to 70 of about 4,372,209 (230)
Hypotension and inflammatory cytokine gene expression triggered by factor Xa-nitric oxide signaling.
The signaling pathway initiated by factor Xa on vascular endothelial cells was investigated. Factor Xa stimulated a 5- to 10-fold increased release of nitric oxide (NO) in a dose-dependent reaction (0.1-2.5 μg/ml) unaffected by the thrombin inhibitor ...
CICALA, CARLA +19 more
core +1 more source
Factor Xa cleavage of tissue factor pathway inhibitor is associated with loss of anticoagulant activity [PDF]
Tissue factor : factor VIIa induced activation of blood coagulation is inhibited by the complex between factor Xa and tissue factor pathway inhibitor (factor Xa : TFPI).
Hemker, H. Coenraad +13 more
core +1 more source
Modulation of Local Environment for Selective Bicarbonate Conversion to Multi‐Carbon Products
Highly porous Cu electrode partially coated with an ionomer/carbon composite enables efficient conversion of bicarbonate to multi‐carbon products. By regulating the local reaction microenvironment, this strategy overcomes selectivity and reaction‐rate limitations, achieving Faradaic efficiencies of 43% for ethylene and 60% for total multi‐carbon ...
Tai Nguyen +15 more
wiley +1 more source
Mapping of the factor Xa-binding site on factor Va by site-directed mutagenesis.
Activated coagulation factor V functions as a cofactor to factor Xa in the conversion of prothrombin to thrombin. Based on introduction of extra carbohydrate side chains in recombinant factor V, we recently proposed several regions in factor Va to be ...
Dahlbäck, Björn +10 more
core +1 more source
The authors evaluated six machine‐learned interatomic potentials for simulating threshold displacement energies and tritium diffusion in LiAlO2 essential for tritium production. Trained on the same density functional theory data and benchmarked against traditional models for accuracy, stability, displacement energies, and cost, Moment Tensor Potential ...
Ankit Roy +8 more
wiley +1 more source
The currently available oral anti-Xa agents are claimed to produce their anticoagulant and antithrombotic effects solely by the inhibition of factor Xa.
Fakiha Siddiqui BDS +5 more
doaj +1 more source
Association of anticoagulant therapy dosing with laboratory biomarkers and clinical outcomes in critically ill COVID-19 patients in the ICU [PDF]
Background/Aim. In immunothrombotic disorders such as coronavirus disease 2019 (COVID-19), D-dimer levels are frequently elevated, reflecting increased fibrin formation and turnover. Additional biomarkers, such as the neutrophil-to-lymphocyte ratio (NLR)
Vasković Igor +5 more
doaj +1 more source
Osteosarcoma cell-calcium signaling through tissue factor-factor VIIa complex and factor Xa
The cells responsible for bone formation express protease- activated receptors. Although serine protease thrombin has been shown to elicit functional responses in bone cells that impact on cell survival and alkaline phosphatase activity, nothing is known
Pochet, Roland +3 more
core +1 more source
Reversing factor Xa inhibitors – clinical utility of andexanet alfa
Scott Kaatz,1 Hardik Bhansali,1 Joseph Gibbs,2 Robert Lavender,3 Charles E Mahan,4 David G Paje5 1Division of Hospital Medicine, 2Department of Internal Medicine, Henry Ford Hospital, Detroit, MI, 3Division of General Internal Medicine, University of ...
Gibbs J +5 more
core
Coagulation proteases were tested in a rat model of acute inflammation. Subplantar injection of Factor Xa (10-30 microg) produced a time- and dose-dependent edema in the rat paw, and potentiated carrageenin-induced edema.
G. Ambrosini +13 more
core +1 more source

